4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-003245
EVP, GM Gene Therapy sold 27,894 shares at $3.12 ($87,029)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Buck Jill EVP, GM Gene Therapy | 2021-01-08 | Sale | −27,894 | $3.12 | $87,029 | 199,516 | D |
| Open-market sales · 27,894 sh · avg $3.12 · $87,029 | |||||||
Loading xslF345X03/doc4.xml…